Sales

586.7

557.1

1,778.2

1,027.4

340.1

359.3

1,121.5

1,109.0

Royalty, license and commission income

1.6

1.9

5.1

5.6

1.5

1.1

2.3

5.6

Total revenues

588.3

559.0

1,783.2

1,033.0

341.7

360.4

1,123.8

1,114.5

Gross margin

340.3

290.6

1,026.3

545.1

195.7

241.5

658.5

733.5

Marketing and selling expenses

–150.8

–136.7

–444.1

–258.2

–33.3

–34.6

–99.7

–99.0

Royalty, license and commission expenses

–3.7

–3.2

–10.7

–6.2

–0.6

–1.9

–3.5

–7.8

Administration expenses

–26.9

–26.2

–80.6

–48.3

–8.9

–10.6

–26.6

–30.6

Other operating expenses and income

–24.4

–33.8

–81.2

–94.6

–5.3

–11.2

–31.3

–49.5

Research and development

–33.7

–30.0

–98.2

–43.3

–34.3

–33.4

–100.9

–94.7

Operating result

53.1

13.2

171.4

47.0

112.9

148.7

386.0

447.6

Exceptional items

–

–

–

–

–0.1

–

157.3

–

Earnings before interest and tax (EBIT)

53.1

13.2

171.4

47.0

112.8

148.7

543.3

447.6

Net operating assets**

–

–

6,397.0

6,435.7

–

–

1,253.7

1,289.8

Segment liabilities**

–

–

–323.0

–361.4

–

–

–159.7

–166.8

Capital spending on property, plant and equipment

22.2

22.3

64.4

42.4

18.0

20.9

43.8

46.1

Investments in intangible assets

5.4

2.0

8.1

4.1

–

0.7

1.3

2.3

Depreciation and amortization

–70.1

–69.3

–210.7

–92.5

–25.2

–25.5

–77.1

–72.5

Impairment losses

–

–1.6

–2.0

–1.6

–

–

–9.4

–16.4

Net cash flows from operating activities

126.9

29.9

283.1

95.5

171.3

184.0

455.3

468.0

Net cash flows from investing activities

–100.4

–4,861.8

–146.0

–4,886.7

–17.8

–25.2

150.7

–49.5

Free cash flow

26.6

–4,831.9

137.1

–4,791.2

153.5

158.9

606.0

418.5

Underlying free cash flow

101.9

101.8

228.8

142.6

153.5

165.4

405.1

425.0

FCR in %

17.3

18.2

12.8

13.8

44.9

45.9

36.0

38.1

ROS in %

9.0

2.4

9.6

4.5

33.0

41.2

34.3

40.2

Chemicals

€ million

Q3
2011

Q3
2010

Jan.–Sep.
2011

Jan.–Sep.
2010

Sales

926.8

916.4

2,899.7

2,136.4

Royalty, license and commission income

3.1

3.0

7.4

11.1

Total revenues

929.9

919.4

2,907.1

2,147.5

Gross margin

535.9

532.1

1,684.8

1,278.6

Marketing and selling expenses

–184.1

–171.3

–543.9

–357.2

Royalty, license and commission expenses

–4.3

–5.1

–14.2

–14.0

Administration expenses

–35.8

–36.8

–107.2

–78.9

Other operating expenses and income

–29.7

–45.0

–112.5

–144.1

Research and development

–68.0

–63.5

–199.1

–138.0

Operating result

166.0

161.8

557.4

494.6

Exceptional items

–0.1

–

157.3

–

Earnings before interest and tax (EBIT)

165.9

161.8

714.7

494.6

Net operating assets**

–

–

7,650.6

7,725.3

Segment liabilities**

–

–

–482.6

–528.2

Capital spending on property, plant and equipment

40.1

43.1

108.2

88.5

Investments in intangible assets

5.4

2.8

9.3

6.4

Depreciation and amortization

–95.3

–94.8

–287.8

–164.9

Impairment losses

–

–1.6

–11.5

–18.0

Net cash flows from operating activities

298.3

213.9

738.4

563.5

Net cash flows from investing activities

–118.2

–4,886.9

4.7

–4,936.2

Free cash flow

180.1

–4,673.0

743.1

–4,372.7

Underlying free cash flow

255.4

267.3

633.9

567.6

FCR in %

27.5

29.1

21.8

26.4

ROS in %

17.9

17.6

19.2

23.0